One of the hypothesis to explain these results relies in the large number of overexpressed tumoral antigens (Her-2/neu, CEA, MUC-1, etc.)in breast cancer released after CT, which represent an excellent target for an immune environment boosted by GM-CSF [55]. This evidence concerns the gene CSF2 and breast carcinoma.